id	sid	eid	entity	type
ajlm-1628	1	1	s. singu school of pharmacy	ORG
ajlm-1628	1	2	university of namibia	ORG
ajlm-1628	1	3	windhoek	GPE
ajlm-1628	1	4	namibia	GPE
ajlm-1628	1	5	helen morrison school	PERSON
ajlm-1628	1	6	university of namibia	ORG
ajlm-1628	1	7	windhoek	GPE
ajlm-1628	1	8	namibia lydia irengeya school	ORG
ajlm-1628	1	9	university of namibia	ORG
ajlm-1628	1	10	windhoek	GPE
ajlm-1628	1	11	namibia	GPE
ajlm-1628	1	12	roger k. verbeeck school	PERSON
ajlm-1628	1	13	university of namibia	ORG
ajlm-1628	1	14	windhoek	GPE
ajlm-1628	1	15	namibia	GPE
ajlm-1628	2	1	morrison h	GPE
ajlm-1628	2	2	irengeya l	ORG
ajlm-1628	3	1	windhoek central hospital	ORG
ajlm-1628	3	2	namibia	GPE
ajlm-1628	4	1	afr j	PERSON
ajlm-1628	5	1	2022;11(1	CARDINAL
ajlm-1628	7	1	windhoek central hospital	ORG
ajlm-1628	7	2	namibia	GPE
ajlm-1628	7	3	s. singu	PERSON
ajlm-1628	7	4	helen morrison	PERSON
ajlm-1628	7	5	lydia irengeya	PERSON
ajlm-1628	7	6	roger k. verbeeck	PERSON
ajlm-1628	7	7	22	CARDINAL
ajlm-1628	7	8	14	CARDINAL
ajlm-1628	7	9	2022	CARDINAL
ajlm-1628	7	10	21	CARDINAL
ajlm-1628	7	11	2022	CARDINAL
ajlm-1628	15	1	56	CARDINAL
ajlm-1628	15	2	93	CARDINAL
ajlm-1628	17	1	41.1%	PERCENT
ajlm-1628	17	2	46.4%	PERCENT
ajlm-1628	17	3	12.5%	PERCENT
ajlm-1628	17	4	10 μg/ml	QUANTITY
ajlm-1628	17	5	20 μg/ml	QUANTITY
ajlm-1628	18	1	1 μg/ml	QUANTITY
ajlm-1628	18	2	2 μg/ml	QUANTITY
ajlm-1628	18	3	57.1%	PERCENT
ajlm-1628	19	1	87.1%	PERCENT
ajlm-1628	19	2	50 μg/ml	QUANTITY
ajlm-1628	19	3	100 μg/ml	QUANTITY
ajlm-1628	19	4	12.9%	PERCENT
ajlm-1628	20	1	91.4%	PERCENT
ajlm-1628	20	2	between 2.5 μg/ml and 20 μg/ml	CARDINAL
ajlm-1628	24	1	north american	NORP
ajlm-1628	24	2	2013	DATE
ajlm-1628	24	3	3.3%	PERCENT
ajlm-1628	25	1	2c9	CARDINAL
ajlm-1628	25	2	2c19	CARDINAL
ajlm-1628	25	3	first	ORDINAL
ajlm-1628	26	1	zero	CARDINAL
ajlm-1628	26	2	50.0%	PERCENT
ajlm-1628	27	1	ω	CARDINAL
ajlm-1628	27	2	40.0%	PERCENT
ajlm-1628	27	3	10.0%).6	ORDINAL
ajlm-1628	29	1	90%	PERCENT
ajlm-1628	32	1	10 μg/ml to	QUANTITY
ajlm-1628	32	2	1 μg/ml	QUANTITY
ajlm-1628	32	3	50 μg/ml to	QUANTITY
ajlm-1628	32	4	2.5 μg/ml to	QUANTITY
ajlm-1628	32	5	the windhoek central hospital	ORG
ajlm-1628	32	6	windhoek	GPE
ajlm-1628	32	7	namibia	GPE
ajlm-1628	33	1	two	CARDINAL
ajlm-1628	34	1	the ministry of health and social services	ORG
ajlm-1628	34	2	the republic of namibia	GPE
ajlm-1628	34	3	hm2019	PERSON
ajlm-1628	37	1	windhoek central hospital	ORG
ajlm-1628	37	2	namibia	GPE
ajlm-1628	38	1	between january 2013	DATE
ajlm-1628	38	2	july 2019	DATE
ajlm-1628	41	1	the namibia institute of pathology	ORG
ajlm-1628	41	2	6000	CARDINAL
ajlm-1628	41	3	roche diagnostics international	ORG
ajlm-1628	41	4	switzerland	GPE
ajlm-1628	42	1	abbott	GPE
ajlm-1628	42	2	i2000	ORG
ajlm-1628	42	3	abbott laboratories	ORG
ajlm-1628	42	4	chicago	GPE
ajlm-1628	42	5	illinois	GPE
ajlm-1628	42	6	united states	GPE
ajlm-1628	43	1	pht	ORG
ajlm-1628	43	2	pht	ORG
ajlm-1628	43	3	1	CARDINAL
ajlm-1628	44	1	10 μg/ml to	QUANTITY
ajlm-1628	44	2	1 μg/ml	QUANTITY
ajlm-1628	44	3	α vpa	PERSON
ajlm-1628	44	4	2	CARDINAL
ajlm-1628	44	5	cu vpa	PERSON
ajlm-1628	44	6	vpa	PERSON
ajlm-1628	45	1	3	CARDINAL
ajlm-1628	46	1	50 μg/ml to	QUANTITY
ajlm-1628	46	2	2.5 μg/ml	QUANTITY
ajlm-1628	46	3	20.0 μg/	QUANTITY
ajlm-1628	47	1	10	CARDINAL
ajlm-1628	47	2	microsoft corporation	ORG
ajlm-1628	47	3	redmond	GPE
ajlm-1628	47	4	washington	GPE
ajlm-1628	47	5	united states	GPE
ajlm-1628	48	1	1661	CARDINAL
ajlm-1628	48	2	between january 2013	DATE
ajlm-1628	48	3	july 2019	DATE
ajlm-1628	48	4	windhoek central hospital	ORG
ajlm-1628	49	1	fifty-six	CARDINAL
ajlm-1628	49	2	93	CARDINAL
ajlm-1628	51	1	two months to 66 years	DATE
ajlm-1628	52	1	35	CARDINAL
ajlm-1628	52	2	± s.d	ORG
ajlm-1628	53	1	23.5 ±	CARDINAL
ajlm-1628	53	2	± s.d	ORG
ajlm-1628	53	3	23.8 ±	CARDINAL
ajlm-1628	53	4	1	CARDINAL
ajlm-1628	54	1	forty-five percent	PERCENT
ajlm-1628	55	1	28%	PERCENT
ajlm-1628	56	1	1	CARDINAL
ajlm-1628	56	2	windhoek central hospital	ORG
ajlm-1628	56	3	windhoek	GPE
ajlm-1628	56	4	namibia	GPE
ajlm-1628	56	5	2013 to 2019	DATE
ajlm-1628	57	1	56	CARDINAL
ajlm-1628	57	2	0.1 μg/ml	QUANTITY
ajlm-1628	57	3	12.6 ± 8.20 μg/ml	MONEY
ajlm-1628	57	4	1	CARDINAL
ajlm-1628	58	1	23	CARDINAL
ajlm-1628	58	2	41.1%	PERCENT
ajlm-1628	58	3	10 μg/ml to	QUANTITY
ajlm-1628	58	4	1	CARDINAL
ajlm-1628	59	1	26	CARDINAL
ajlm-1628	59	2	46.4%	PERCENT
ajlm-1628	59	3	seven	CARDINAL
ajlm-1628	59	4	12.5%	PERCENT
ajlm-1628	60	1	16	CARDINAL
ajlm-1628	60	2	28.6%	PERCENT
ajlm-1628	60	3	1 μg/ml to	QUANTITY
ajlm-1628	61	1	eight	CARDINAL
ajlm-1628	61	2	14.3%	PERCENT
ajlm-1628	61	3	32	CARDINAL
ajlm-1628	61	4	57.1%	PERCENT
ajlm-1628	62	1	1	CARDINAL
ajlm-1628	62	2	56	CARDINAL
ajlm-1628	62	3	windhoek central hospital	ORG
ajlm-1628	62	4	windhoek	GPE
ajlm-1628	62	5	namibia	GPE
ajlm-1628	62	6	january 2013 to july 2019	DATE
ajlm-1628	64	1	81	CARDINAL
ajlm-1628	64	2	87.1%	PERCENT
ajlm-1628	64	3	50 μg/ml to	QUANTITY
ajlm-1628	64	4	2	CARDINAL
ajlm-1628	65	1	9.0%	PERCENT
ajlm-1628	65	2	39.0%	PERCENT
ajlm-1628	66	1	12	CARDINAL
ajlm-1628	66	2	12.9%	PERCENT
ajlm-1628	67	1	24.0%	PERCENT
ajlm-1628	67	2	7.0%	PERCENT
ajlm-1628	67	3	67.0%	PERCENT
ajlm-1628	68	1	91.4%	PERCENT
ajlm-1628	68	2	2.5 μg/ml to	QUANTITY
ajlm-1628	69	1	seven	CARDINAL
ajlm-1628	69	2	7.5%	PERCENT
ajlm-1628	69	3	only one	CARDINAL
ajlm-1628	69	4	1.1%	PERCENT
ajlm-1628	70	1	2	CARDINAL
ajlm-1628	70	2	93	CARDINAL
ajlm-1628	70	3	windhoek central hospital	ORG
ajlm-1628	70	4	windhoek	GPE
ajlm-1628	70	5	namibia	GPE
ajlm-1628	70	6	january 2013 to july 2019	DATE
ajlm-1628	73	1	two	CARDINAL
ajlm-1628	75	1	less than one-third	CARDINAL
ajlm-1628	75	2	over half	CARDINAL
ajlm-1628	78	1	noval et al	PERSON
ajlm-1628	78	2	2-fold	CARDINAL
ajlm-1628	78	3	41.1%	PERCENT
ajlm-1628	78	4	28.6%	PERCENT
ajlm-1628	80	1	9.0%	PERCENT
ajlm-1628	80	2	39.0%	PERCENT
ajlm-1628	80	3	10.0%	PERCENT
ajlm-1628	80	4	60.0%	PERCENT
ajlm-1628	80	5	15.0%	PERCENT
ajlm-1628	80	6	89.0%	PERCENT
ajlm-1628	80	7	riker et al.24	PERSON
ajlm-1628	80	8	12.9%	PERCENT
ajlm-1628	80	9	91.4%	PERCENT
ajlm-1628	83	1	2 μg/ml	QUANTITY
ajlm-1628	88	1	two	CARDINAL
ajlm-1628	92	1	h.m.	GPE
ajlm-1628	92	2	l.i.	PERSON
ajlm-1628	98	1	spanaki mv	PERSON
ajlm-1628	98	2	mirski ma	PERSON
ajlm-1628	99	1	neurosurg clin n am.	ORG
ajlm-1628	100	1	ritzl ek	PERSON
ajlm-1628	100	2	lewin iii jj	PERSON
ajlm-1628	100	3	mirski ma	PERSON
ajlm-1628	103	1	2018;22(1):153	CARDINAL
ajlm-1628	104	1	https://doi.org/10.1186/s13054-018-2066-1 allen	PERSON
ajlm-1628	106	1	curr opin	PERSON
ajlm-1628	107	1	2019;25(2):117–125	CARDINAL
ajlm-1628	108	1	anderson gd	PERSON
ajlm-1628	108	2	collins rj	PERSON
ajlm-1628	110	1	burton	PERSON
ajlm-1628	110	2	shaw	PERSON
ajlm-1628	110	3	applied pharmacokinetics & pharmacodynamics	ORG
ajlm-1628	111	1	4th	ORDINAL
ajlm-1628	111	2	philadelphia	GPE
ajlm-1628	111	3	lippincott williams & wilkins	ORG
ajlm-1628	111	4	2006	DATE
ajlm-1628	112	1	491–511	MONEY
ajlm-1628	113	1	winter	DATE
ajlm-1628	113	2	tozer tn	PERSON
ajlm-1628	114	1	burton	PERSON
ajlm-1628	114	2	shaw	PERSON
ajlm-1628	114	3	applied pharmacokinetics & pharmacodynamics	ORG
ajlm-1628	115	1	4th	ORDINAL
ajlm-1628	115	2	philadelphia	GPE
ajlm-1628	115	3	lippincott williams & wilkins	ORG
ajlm-1628	115	4	2006	DATE
ajlm-1628	117	1	463–490	CARDINAL
ajlm-1628	119	1	2013;23(4):236–241	CARDINAL
ajlm-1628	120	1	patsalos pn	PERSON
ajlm-1628	124	1	klein te	PERSON
ajlm-1628	124	2	altman	ORG
ajlm-1628	127	1	2012;22(6):466–470	CARDINAL
ajlm-1628	127	2	garcia sanchez mj	PERSON
ajlm-1628	127	3	alonso gonzales ac	PERSON
ajlm-1628	127	4	santos buelga	PERSON
ajlm-1628	127	5	dominguez-gil a.	NORP
ajlm-1628	128	1	j clin pharm	PERSON
ajlm-1628	129	1	1993;18(3):191–197	CARDINAL
ajlm-1628	130	1	m. plasma protein	PERSON
ajlm-1628	132	1	1980	DATE
ajlm-1628	132	2	2(1):29–37	CARDINAL
ajlm-1628	135	1	j mol sci	PERSON
ajlm-1628	136	1	2021;22(9):4496	ORG
ajlm-1628	137	1	https://doi.org/10.3390/ijms22094496 von winckelmann sl	PERSON
ajlm-1628	137	2	spriet	ORG
ajlm-1628	137	3	willems l.	PERSON
ajlm-1628	141	1	https://doi.org/10.1592/phco.28.11.1391 riker rr	PERSON
ajlm-1628	141	2	gagnon	PERSON
ajlm-1628	144	1	2017;37(4):500–508	CARDINAL
ajlm-1628	146	1	1980;2(4):331344	CARDINAL
ajlm-1628	147	1	riker rr	PERSON
ajlm-1628	147	2	gagnon	PERSON
ajlm-1628	147	3	fraser gl	PERSON
ajlm-1628	149	1	2016;10	CARDINAL
ajlm-1628	149	2	e15e16	DATE
ajlm-1628	150	1	schmidt s	PERSON
ajlm-1628	150	2	derendorf h.	PERSON
ajlm-1628	152	1	2013;102(9):3458–3467	DATE
ajlm-1628	153	1	nj	ORG
ajlm-1628	153	2	robertson m.	PERSON
ajlm-1628	155	1	1992;42(5):988–990	CARDINAL
ajlm-1628	158	1	ann biol clin	PERSON
ajlm-1628	158	2	paris	GPE
ajlm-1628	159	1	1993;51(6):649–650	CARDINAL
ajlm-1628	159	2	hermida	PERSON
ajlm-1628	159	3	jc	PERSON
ajlm-1628	161	1	j pharmacol sci	PERSON
ajlm-1628	162	1	2005;97(4):489–493	CARDINAL
ajlm-1628	163	1	tozer tn.	ORG
ajlm-1628	165	1	melmon kl	PERSON
ajlm-1628	165	2	morelli hf	PERSON
ajlm-1628	167	1	new york	GPE
ajlm-1628	167	2	ny: macmillan	ORG
ajlm-1628	167	3	1978	DATE
ajlm-1628	167	4	1978	DATE
ajlm-1628	168	1	anderson gd	PERSON
ajlm-1628	168	2	pak c	ORG
ajlm-1628	168	3	doane kw	PERSON
ajlm-1628	168	4	winter	DATE
ajlm-1628	169	1	ann pharmacother	PERSON
ajlm-1628	170	1	1997;31(3):279–284	CARDINAL
ajlm-1628	171	1	kane	PERSON
ajlm-1628	171	2	tesoro ep	PERSON
ajlm-1628	172	1	winter	DATE
ajlm-1628	173	1	ann pharmacother	PERSON
ajlm-1628	174	1	2013;47(5):628–636	CARDINAL
ajlm-1628	175	1	noval m	PERSON
ajlm-1628	175	2	seung h	ORG
ajlm-1628	175	3	armahizer m. evaluation	PERSON
ajlm-1628	179	1	perbet	ORG
ajlm-1628	182	1	2004;30:1247	CARDINAL
ajlm-1628	183	1	smetana ks	GPE
ajlm-1628	183	2	thompson bastin ml	PERSON
ajlm-1628	186	1	wolf gh	PERSON
ajlm-1628	186	2	mcclain	PERSON
ajlm-1628	186	3	dodson b	PERSON
ajlm-1628	186	4	mcmanus ml	FAC
ajlm-1628	188	1	cheng w	PERSON
ajlm-1628	188	2	kiang tkl	PERSON
ajlm-1628	188	3	ensom mhh	PERSON
ajlm-1628	189	1	winter	DATE
ajlm-1628	190	1	j hosp pharm	ORG
ajlm-1628	191	1	2016;69(4):269–279	CARDINAL
ajlm-1628	192	1	https://doi.org/10.4212/cjhp.v69i4.1573	CARDINAL
ajlm-1628	192	2	kiang tkl	PERSON
ajlm-1628	192	3	ensom mhh	PERSON
ajlm-1628	194	1	ann pharmacother	PERSON
ajlm-1628	195	1	2016;50(4):311–325	CARDINAL
ajlm-1628	196	1	javadi s-s	PERSON
ajlm-1628	196	2	mehrpooya m.	PERSON
ajlm-1628	197	1	clin pharmacol	ORG
ajlm-1628	198	1	2018;10:183–190	CARDINAL
ajlm-1628	199	1	phillips km	PERSON
ajlm-1628	199	2	chung dy	PERSON
ajlm-1628	199	3	rosenthal es	PERSON
ajlm-1628	202	1	2020;42(4):6	CARDINAL
ajlm-1628	203	1	https://doi.org/10.1097/ftd.0000000000000739 tseng y-j	PERSON
ajlm-1628	203	2	huang s-y	PERSON
ajlm-1628	203	3	kuo c-h	PERSON
ajlm-1628	203	4	wang c-y	PERSON
ajlm-1628	203	5	wang k-c	PERSON
ajlm-1628	203	6	wu c-c.	PERSON
ajlm-1628	204	1	plos	PERSON
ajlm-1628	204	2	one	CARDINAL
ajlm-1628	205	1	2020;15(9):e0238201	CARDINAL